LDS/Medical Tests/Mycoplasma pneumoniae Antibody, IgG

Mycoplasma pneumoniae Antibody, IgG

Mycoplasma pneumoniae is an important cause of pneumonia and contributes up to 20% of all community-acquired pneumonias across a wide range of age groups. Within certain susceptible groups such as school-going children, adolescents and young adults, it contributes up to 50% of the cases. Individuals acquire M. pneumoniae through aerosol inhalation. After an incubation period of 2-3 weeks, the individuals develop symptoms of upper respiratory tract infection and tracheobronchitis. About a third of the cases develop pneumonia. Extrapulmonary complications of M. pneumoniae are uncommon and include CNS manifestations such as meningoencephalitis, ascending paralysis, regional neuropathies and movement disorders. It may present as an autoimmune disorder presenting with pericarditis, arthritis, nephritis, mucocutaneous lesions and hemolytic anemia. In an otherwise healthy individual, the disease tends to be mild and requires supportive care and antibiotics in an ambulatory setting; however, in individuals with compromised immune status and/or other co-morbidities, the infections result in hospitalization, severe morbidity and death.

Laboratory diagnosis of M. pneumoniae is challenging and requires a combination of techniques to correctly identify the cases. Considerable levels of prevalence are noted among asymptomatic individuals, identified serologically and by nucleic acid amplification techniques. For this reason, interpretation of these tests requires clinical correlation. Polymerase chain reaction (PCR) yields faster results than culture and serology and has higher sensitivity and specificity than direct antigen detection and nucleic acid hybridization. Several PCR-based tests are commercially available including multiplex PCR, nested PCR and real-time PCR, all of which have reliable laboratory performance.

  • Clinical diagnosis of Mycoplasma pneumoniae infection
  • Treatment and disease management

Positive IgG antibody to Mycoplasma pneumoniae indicates current or past infection. 

 

Negative (Non-reactive)

Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).

Serum (SST) or plasma (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days

Mycoplasma pneumoniae PCR, Mycoplasma pneumoniae Antibodies IgM, upper respiratory culture, viral culture, Respiratory Viral Panel by PCR.

2-5 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Microbiol Infect. 2003 Apr; 9(4):263-73. [PMID: 12667235]
  • J Clin Microbiol. 1994 Jan; 32(1): 11–16. [PMID: 7510308]
  • Curr Opin Infect Dis. 2001 Apr;14(2):181-6. [PMID: 11979130]
  • Manual of Clinical Microbiology, 10th edition, pp. 970-985